MATERIALS AND METHODS
Patients who underwent surgery for localized prostate cancer were
included from the Turkish Urooncology Association (TUA) Prostate Cancer
database. A History of previous treatment (radiotherapy or androgen
deprivation therapy) or active surveillance (AS) were considered as
exclusion criteria from the study. The date of prostate biopsy was
regarded as the date of diagnosis and time to treatment was calculated
as the number of days between the date of surgery and the diagnosis
date. Patients were divided into two groups according the time period
between the diagnosis and surgery; less than or equal to 90 days (group
1) or longer than 90 days (group 2). Surgical pathology results and
oncological outcomes were compared between the two groups.